EUVIMEDEUVIMED entdecken
Crossref

The pharmacokinetics/pharmacodynamics integration of tilmicosin against Mycoplasma synoviae in vitro and in vivo

Xiu Yan iD, Jinxin Liu, Weihuo Li, Shuti Song, Zhaofeng Yao, Yixin Jia, Sheng Yuan, Hong Yang, Nan Zhang

Journal of Veterinary Pharmacology and Therapeutics · 2024

DOI: 10.1111/jvp.13475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2024. Verfasst von Xiu Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Engineering, Foshan University, Foshan, China. Hauptthemen laut MEDLINE: Tylosin, Anti-Bacterial Agents, Chickens, Mycoplasma Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycoplasma synoviae (MS) infection is a serious threat to poultry industry in China. Tilmicosin is a semisynthetic macrolide antibiotic used only in animals and has shown potential efficacy against MS, but there were no reported articles concerning the pharmacokinetics/pharmacodynamics (PK/PD) interactions of tilmicosin against MS in vitro and vivo. This study aimed to assess the antibacterial activity of tilmicosin against MS in vitro and in vivo using PK/PD model to provide maximal efficacy. The minimum inhibitory concentration (MIC) and killing rates of different drug concentrations were measured using the microdilution method in vitro. Then, tilmicosin was administered orally to the MS‐infected chickens at doses of 7.5 and 60 mg/kg, and the PK parameters of tilmicosin in joint dialysates were determined using high‐pressure liquid chromatography/tandem mass spectrometry (HPLC‐MS/MS) combined with the microdialysis technique. The antibacterial effect (△E) was calculated when the infected chickens were administered a single oral dose of tilmicosin at 4, 7.5, 15, 30, and 60 mg/kg b.w. The PK and PD data were fitted using the Sigmoid E max model to evaluate the PK/PD interactions of tilmicosin against MS. The bactericidal activity of tilmicosin against MS was concentration dependent. Furthermore, the PK/PD index of AUC 0–72h /MIC exhibited the most optimal fitting results ( R 2 = .98). The MS load decreased by 1, 2, and 3 Log 10 CFU/mL, then AUC/MIC was determined as 13.99, 20.53, and 28.23 h, respectively, and the bactericidal effect can be achieved when the dose of MS‐infected chickens is at 31.64 mg/kg b.w. The findings of this study hold significant implications for optimizing the treatment regimen for MS infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TylosinAnti-Bacterial AgentsChickensMycoplasma InfectionsPoultry DiseasesMycoplasma synoviaeMicrobial Sensitivity TestsAnimalsDose-Response Relationship, Drug

Stichwörter der Autor:innen

Mycoplasma synoviaeinfection modelpharmacokinetics/pharmacodynamicstilmicosin

Substanzen

TylosintilmicosinAnti-Bacterial Agents

Autor:innen und Institutionen

  • School of Life Science and Engineering, Foshan University, Foshan, China.
  • Laboratory Animal Center, Peking University Shenzhen Graduate School, Shenzhen, China.

ORCID-Profile: Xiu Yan

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yan, X., Liu, J., Li, W., Song, S., Yao, Z., Jia, Y., Yuan, S., Yang, H., & Zhang, N. (2024). The pharmacokinetics/pharmacodynamics integration of tilmicosin against Mycoplasma synoviae in vitro and in vivo. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.13475

Vancouver

Yan X, Liu J, Li W, Song S, Yao Z, Jia Y, et al. The pharmacokinetics/pharmacodynamics integration of tilmicosin against Mycoplasma synoviae in vitro and in vivo. Journal of Veterinary Pharmacology and Therapeutics. 2024. doi:10.1111/jvp.13475

BibTeX
@article{Yan2024,
  author = {Yan, Xiu and Liu, Jinxin and Li, Weihuo and Song, Shuti and Yao, Zhaofeng and Jia, Yixin and Yuan, Sheng and Yang, Hong and Zhang, Nan},
  title = {The pharmacokinetics/pharmacodynamics integration of tilmicosin against Mycoplasma synoviae in vitro and in vivo},
  journal = {Journal of Veterinary Pharmacology and Therapeutics},
  year = {2024},
  doi = {10.1111/jvp.13475}
}
Kostenlos starten →